Overview
- Editors:
-
-
Yasutsugu Shimonishi
-
Osaka University, Japan
Access this book
Other ways to access
Table of contents (285 papers)
-
Protease inhibitors: Biology and inhibition
-
- T. Mimoto, R. Kato, H. Takaku, S. Misawa, T. Fukazawa, S. Nojima et al.
Pages 652-653
-
- E. Jankowska, W. Wiczk, Z. Grzonka
Pages 654-656
-
-
- A. A. Bekhit, H. Matsumoto, H. M. M. Abdel-Rahman, T. Mimoto, S. Nojima, H. Takaku et al.
Pages 660-661
-
- H. M. M. Abdel-Rahman, H. Matsumoto, A. A. Bekhit, T. Mimoto, S. Nojima, H. Takaku et al.
Pages 662-664
-
Peptide pharmacology potential therapeutic application
-
- P. W. Schiller, 1G. Weltrowska, R. Schmidt, T. M. -D. Nguyen, I. Berezowska, Y. Chen et al.
Pages 665-669
-
- S. Froidevaux, A. Heppeler, M. Behe, E. Jermann, A. Otte, J. MÜller-Brand et al.
Pages 670-673
-
- I. Jonassen, S. Havelund, P. Kurtzhals, J. Halstrom, U. Ribel, E. Hasselager et al.
Pages 674-677
-
- H. Süli-Vargha, J. Bódi, H. Medzihradszky-Schweiger, L. Nagy, R. Morandini, G. E. Ghanem
Pages 678-680
-
- Y. Nishiyama, T. Murakami, K. Kurita, N. Yamamoto
Pages 681-683
-
- M. Dathe, D. Macdonald, W. L. Maloy, M. Beyermann, E. Krause, M. Bienert
Pages 684-686
-
- M. Dathe, C. Kaduk, E. Tachikawa, H. Wenschuh, M. Melzig, M. Bienert
Pages 687-688
-
- N. A. Belyaev, E. F. Kolesanova, V. Y. Baronets, N. N. Terebilina, L. F. Panchenko
Pages 689-690
-
- H. Saido-Sakanaka, J. Ishibashi, A. Miyanoshita, M. Yamakawa
Pages 691-692
-
- A. Boldyrev, P. Johnson, Y. Wei, C. Peters, M. Huentelman
Pages 693-694
-
- T. Sasaki, M. Fainzilber, K. Sato
Pages 695-696
-
- H. Matsumoto, K. Hashimoto, Z. Takatsu, S. Shimamura, M. Tomita
Pages 697-698
-
- S. Futaki, R. Tachibana, M. Shono, M. Azumano, M. Niwa, H. Kiwada et al.
Pages 699-700
-
-
- J. Ghosh, I. Kustanovich, Y. Shai, A. Mor
Pages 704-706
About this book
In the late 1980s, Peptide Societies were established in Europe, the United States, and Japan, and more recently, in the Asian and the Pacific Rim regions including Australia, China, and Korea. At the time of the establishment of the American, European and Japanese Peptide Societies, the International Liaison Organizing Committee representing these Peptide Societies, along with the Australian Peptide Society, began discussions for holding international confer ences which would supercede or be held in lieu of the numerous individual meetings, held by the peptide societies of each individual country or region. The representative of the Chinese Peptide Society participated in these discus sion in the International Liaison Organizing Committee at the meeting of the American Peptide Symposium in Nashville, in June 1997. After lengthy discus sions over several years, we agreed to organize and host the International Peptide Symposium in Japan. The First International Peptide Symposium (IPS’97) was held on November 30–December 5, 1997, in Kyoto, and was co sponsored by four Peptide Societies. The attendance at this Symposium was 550 participants, including representatives from 32 different countries. We were very pleased with this outcome and anticipate an even larger attendance for forthcoming Symposia in future years. The revolution and advances in science and technology during the past two decades has caused traditional peptide chemistry to expand to peptide science, spreading from physical science to biology, pharmacology, and medicine.
Editors and Affiliations
-
Osaka University, Japan
Yasutsugu Shimonishi